• Home
  • Auteur/autrice : medrays intell

Breaking Barriers in Cancer Treatment: A Nuclear Medicine Breakthrough The recent news of former U.S. President Joe Biden’s advanced prostate cancer diagnosis brings attention to the ongoing fight against cancer.Millions of people around the world are diagnosed

Securing Europe's Nuclear Medicine Supply Chain: A Call for Collaboration 📖 More than ever before, securing efficient and sustainable supply chains for medical radionuclides is crucial to uphold innovation in nuclear medicine. The MEDraysintell report highlights the

Back from RRFM 2025 – Exciting discussions around the future of medical isotope production ! 🎤 Back from RRFM 2025 – Exciting discussions around the future of medical isotope production !Nicolas Mario had the pleasure to present

France Biotech Event: Spotlight on Nuclear Medicine Innovation ✨Exciting News!Our Head of Medical & Science, Vincent Brechin, Ph.D., will participate tomorrow in a round table discussion organized by France Biotech on the theme: "Nuclear Medicine: Accelerating the

MEDraysintell acquired by NucAdvisor NucAdvisor is proud to announce the acquisition of MEDraysintell a brand with international experts providing first-rate strategic intelligence in nuclear medicine, radiopharmaceutical, cyclotron, proton therapy and brachytherapy. MEDraysintell was created in 2013 by

  • 1
  • 2